Process Development

Information

Production of cell and gene therapy materials requires the utilization of a living system for their manufacture. Catalent’s Gene Therapy team has been developing scalable upstream and downstream manufacturing processes since 1990. With expertise that spans a multitude of production processes, including stable and transient expression in mammalian cells and virally-transduced production in mammalian and insect cells, our technical teams are ready to optimize your therapeutic development.